With GLP-1 medications hailing a healthcare revolution, and the consumerisation of their accessibility - notably for weight loss - it is no surprise they create increasingly dynamic social conversation. While such conversation provides invaluable, first-hand insight into the motivations and influences of today's healthcare consumer, how do you separate the noise from the strategic signal?

Ipsos Synthesio's proprietary Signals GenAI tool decodes millions of real-time social media conversations about GLP-1s and transforms them into actionable intelligence. In this series of modular reports, we break down the social chatter and what it means for brands in the GLP-1 space. Choose the specific module that aligns with your strategic priority or combine them for a more holistic view of the market narrative.

Whether complementing existing research or answering a standalone business question, this series is your essential guide to understanding the real-world GLP-1 discussion and harnessing the power of the consumer.